Tashkent, Uzbekistan (UzDaily.com) -- President of Uzbekistan Shavkat Mirziyoyev held a meeting on issues of regulating the pharmaceutical sector, providing the population with high-quality and safe medicines.

The world is experiencing growth in the pharmaceutical industry, and new types and compositions of medicines are appearing. This necessitates constant monitoring of their quality, identification and analysis of side effects.

On 23 January, the President signed the Decree “On additional measures to regulate the pharmaceutical industry.”

Thus, organizations that produce and sell medicines and medical products are responsible for ensuring the quality and safety of their products. Special rules of state control will be established for them.

A system is being created aimed at promptly identifying and responding to threats associated with the use of medicines. For this purpose, the “Good Pharmacovigilance Practices - GVP” standard will be introduced, and an electronic database on side effects of drugs will be created in the Ministry of Health. Prompt information will be provided to medical workers and the public about such actions.

Customs and free warehouses where medicines and medical supplies are stored will be gradually brought into compliance with the requirements of the Good Storage Practices - GSP rules. The Center for Good Practices under the Pharmaceutical Industry Development Agency is being reorganized into a government agency.

Advertising of drugs and dietary supplements on television and radio channels will be allowed only on the basis of the conclusion of a special council that will be created under the Ministry of Health.

The head of our state, pointing out the importance of regulating the industry for public health and the economy, gave additional instructions on organizing the effective implementation of the decree.